Fecal microbiota transplantation stimulates type 2 and tolerogenic immune responses in a mouse model

Clostridioides difficile infection (CDI) is the leading hospital-acquired infection in North America. While previous work on fecal microbiota transplantation (FMT), a highly effective treatment for CDI, has focused on colonization resistance mounted against C. difficile by FMT-delivered commensals,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Anaerobe 2024-04, Vol.86, p.102841-102841, Article 102841
Hauptverfasser:	Moreau, G. Brett, Naz, Farha, Petri, William A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Clostridioides difficile Clostridioides difficile - immunology Clostridium Infections - immunology Clostridium Infections - microbiology Clostridium Infections - therapy Disease Models, Animal Dysbiosis - therapy Fecal microbiota transplantation Fecal Microbiota Transplantation - methods Gastrointestinal Microbiome Immune Tolerance Intestinal dysbiosis Mice Mice, Inbred C57BL Microbiota signaling Tolerogenic immunity Type 2 immunity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!